Your browser doesn't support javascript.
loading
Cardiac effects of amiselimod compared with fingolimod and placebo: results of a randomised, parallel-group, phase I study in healthy subjects.
Harada, Tomohiko; Wilbraham, Darren; de La Borderie, Guillemette; Inoue, Shinsuke; Bush, Jim; Camm, A John.
Afiliação
  • Harada T; Mitsubishi Tanabe Pharma Europe Ltd., Dashwood House, 69 Old Broad Street, London, EC2M 1QS, UK.
  • Wilbraham D; Mitsubishi Tanabe Pharma Europe Ltd., Dashwood House, 69 Old Broad Street, London, EC2M 1QS, UK.
  • de La Borderie G; Mitsubishi Tanabe Pharma Europe Ltd., Dashwood House, 69 Old Broad Street, London, EC2M 1QS, UK.
  • Inoue S; Mitsubishi Tanabe Pharma Corporation, 17-10, Nihonbashi-Koamicho, Chuo-ku, Tokyo, 103-8405, Japan.
  • Bush J; Principal Investigator, Covance CRU Ltd., Springfield House, Hyde Street, Leeds, LS2 9LH, UK.
  • Camm AJ; Cardiovascular and Cell Sciences Research Institute, St. George's University of London, London, SW17 0RE, UK.
Br J Clin Pharmacol ; 83(5): 1011-1027, 2017 05.
Article em En | MEDLINE | ID: mdl-27921320
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Propanolaminas / Receptores de Lisoesfingolipídeo / Cloridrato de Fingolimode / Imunossupressores Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Propanolaminas / Receptores de Lisoesfingolipídeo / Cloridrato de Fingolimode / Imunossupressores Tipo de estudo: Clinical_trials / Etiology_studies Limite: Adult / Humans / Male / Middle aged Idioma: En Ano de publicação: 2017 Tipo de documento: Article